Sponsored by:

Molecular Imaging: Page 423

IBA's interim Q3 report shows mixed results
By AuntMinnie.com staff writers
Sales are up more than 50% for the first nine months of 2008 for radiopharmaceutical firm Ion Beam Applications (IBA), but the bottom line is expected to take a hit.
November 18, 2008
Dilon partners with Terason
By AuntMinnie.com staff writers
Scintimammography developer Dilon Technologies and Terason will combine their respective technologies in molecular breast imaging and ultrasound.
November 17, 2008
Dual-time-point FDG-PET/CT improves breast imaging accuracy
By Kate Madden Yee
Recent study results suggest that dual-time-point imaging with acquisition in the prone position improves PET/CT accuracy in patients with suspected breast cancer over single-time-point PET/CT. However, for lesions smaller than 10 mm, MRI shows higher sensitivity and should be preferred, according to the researchers.
November 17, 2008
2008 11 17 15 20 23 842 Figure4 B Thumb
ART posts revenue gain in Q3
By AuntMinnie.com staff writers
Optical molecular imaging developer ART Advanced Research Technologies credits its transition to a direct distribution model for a gain in revenues in the third quarter.
November 16, 2008
PET, PiB support cognitive reserve hypothesis in Alzheimer's
By Wayne Forrest
A new study has found that people with more education appear to score higher on cognitive tests, despite having evidence of brain plaques associated with Alzheimer's disease. Researchers used the PET radiotracer carbon-11-labeled Pittsburgh Compound B (C-11 PiB) to image fibrillar beta-amyloid pathology in vivo.
November 13, 2008
Cardiolite use dropped in September
By AuntMinnie.com staff writers
A new market research report indicates that use of the Cardiolite radiopharmaceutical from Lantheus Medical Imaging dropped 9% in September compared to the previous year, but the agent still has a double-digit lead in market share.
November 12, 2008
Physician vacations affect IsoRay revenue in Q1
By AuntMinnie.com staff writers
Medical isotope developer IsoRay posted lower revenues for its first quarter.
November 12, 2008
Molecular Insight reports Q3 financials
By AuntMinnie.com staff writers
Radiopharmaceutical developer Molecular Insight Pharmaceuticals announced financial results for its third-quarter and nine-month periods.
November 12, 2008
MarketStat #53: Nuclear medicine -- Average waiting time
As of this 2008 census, 48% of the nuclear medicine sites reported waiting times for a nonemergency outpatient visit of less than one day.
November 12, 2008
2008 11 12 16 07 43 220 Marketstat 53
CT for cardiac triage; ASE on echo contrast; nuke med rebounds
By Brian Casey
November 10, 2008
IMV: Nuclear med procedures up in 2007
By AuntMinnie.com staff writers
The number of patients receiving nuclear medicine increased in the U.S. last year, reversing a downward trend from 2006. An estimated 15.7 million patients received nuclear imaging procedures in 2007, representing a gain of 3% from 15.2 million in 2006.
November 10, 2008
2008 11 11 12 03 32 250 2008 11 11 Nuc Med Sites Patients
Molecular Insight reports positive trial results
By AuntMinnie.com staff writers
Molecular Insight Pharmaceuticals said that a phase IIB clinical trial of its Zemiva radiopharmaceutical has yielded positive results.
November 9, 2008
Previous Page
Page 423 of 616
Next Page